Endoplasmic reticulum oxidoreductin-1-like β (ERO1lβ) regulates susceptibility to endoplasmic reticulum stress and is induced by insulin flux in β-cells

Endocrinology. 2011 Jul;152(7):2599-608. doi: 10.1210/en.2010-1420. Epub 2011 May 3.

Abstract

Hyperglycemia increases insulin flux through the endoplasmic reticulum (ER) of pancreatic β-cells, and the unfolded protein response pathway is required to enhance insulin processing. Pancreatic and duodenal homeobox 1 (PDX1), a key pancreatic transcription factor, regulates insulin along with targets involved in insulin processing and secretion. Here we find that PDX1 is a direct transcriptional regulator of ER oxidoreductin-1-like β (Ero1lβ), which maintains the oxidative environment of the ER to facilitate disulfide bond formation. PDX1 deficiency reduced Ero1lβ transcript levels in mouse islets and mouse insulinoma (MIN6) cells; moreover, PDX1 occupied the Ero1lβ promoter in β-cells. ERO1lβ levels were induced by high glucose concentrations and by the reducing agent dithiothreitol, indicating potential roles in adaptation to increased oxidative protein folding load in the β-cell ER. In MIN6 cells, small interfering RNA-mediated silencing of Ero1lβ decreased insulin content and increased susceptibility to ER stress-induced apoptosis. These findings demonstrate roles for the PDX1 target ERO1lβ in maintaining insulin content and regulating cell survival during ER stress.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • Calcium Signaling / drug effects
  • Cell Line
  • Gene Silencing
  • Glycoproteins / antagonists & inhibitors
  • Glycoproteins / genetics
  • Glycoproteins / physiology*
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / metabolism
  • Hyperglycemia / metabolism
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacokinetics
  • Hypoglycemic Agents / pharmacology*
  • Insulin / chemistry
  • Insulin / pharmacokinetics
  • Insulin / pharmacology*
  • Islets of Langerhans / drug effects*
  • Islets of Langerhans / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Organ Culture Techniques
  • Oxidative Stress* / drug effects
  • Oxidoreductases
  • Promoter Regions, Genetic
  • RNA, Small Interfering
  • Reducing Agents / toxicity
  • Trans-Activators / genetics
  • Trans-Activators / metabolism

Substances

  • Glycoproteins
  • Homeodomain Proteins
  • Hypoglycemic Agents
  • Insulin
  • RNA, Small Interfering
  • Reducing Agents
  • Trans-Activators
  • pancreatic and duodenal homeobox 1 protein
  • Ero1l protein, mouse
  • Oxidoreductases